Literature DB >> 18938136

Homotrimeric complexes are the dominant assembly state of native P2X7 subunits.

Annette Nicke1.   

Abstract

P2X receptors (P2XRs) are trimeric ATP-gated cation channels. Seven subunits have been cloned. P2X4 and P2X7 subunits show overlapping expression and both subunits are involved in pathophysiological processes such as inflammatory and neuropathic pain. A recent study provides evidence for heteromeric P2X4/7Rs. In this study, subtype-specific antibodies in combination with BN-PAGE are used to directly visualize P2XR complexes solubilized from membrane extracts of native tissues. The results show specific P2X7R and P2X4R staining in many tissues. The P2X7 complex has a clearly different size than the P2X4 complex but is likewise composed of three subunits. No complexes corresponding to more than three subunits could be detected. Also, no complexes of intermediate size or reactive to both antibodies were detected. These data suggest that either heteromerization between P2X4 and P2X7 subunits results not in stable heteromeric complexes or P2X4/7 heteromers do not represent a dominant subtype in the tissues investigated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938136     DOI: 10.1016/j.bbrc.2008.10.042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  45 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

Review 2.  The role of P2X7 receptors in tissue fibrosis: a brief review.

Authors:  Daniela Gentile; Mariarita Natale; Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Franco Laghi-Pasini
Journal:  Purinergic Signal       Date:  2015-08-29       Impact factor: 3.765

3.  Analysis of assembly and trafficking of native P2X4 and P2X7 receptor complexes in rodent immune cells.

Authors:  Miyyada Boumechache; Marianela Masin; J Michael Edwardson; Dariusz C Górecki; Ruth Murrell-Lagnado
Journal:  J Biol Chem       Date:  2009-03-20       Impact factor: 5.157

4.  More cross-talk between purinergic receptors.

Authors:  Ruth Murrell-Lagnado
Journal:  J Physiol       Date:  2009-06-15       Impact factor: 5.182

5.  P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers.

Authors:  L S Antonio; A P Stewart; X J Xu; W A Varanda; R D Murrell-Lagnado; J M Edwardson
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 6.  Activation and regulation of purinergic P2X receptor channels.

Authors:  Claudio Coddou; Zonghe Yan; Tomas Obsil; J Pablo Huidobro-Toro; Stanko S Stojilkovic
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

7.  ATP binding site mutagenesis reveals different subunit stoichiometry of functional P2X2/3 and P2X2/6 receptors.

Authors:  Ralf Hausmann; Mandy Bodnar; Ronja Woltersdorf; Haihong Wang; Martin Fuchs; Nanette Messemer; Ying Qin; Janka Günther; Thomas Riedel; Marcus Grohmann; Karen Nieber; Günther Schmalzing; Patrizia Rubini; Peter Illes
Journal:  J Biol Chem       Date:  2012-02-29       Impact factor: 5.157

Review 8.  Trimeric intracellular cation channels and sarcoplasmic/endoplasmic reticulum calcium homeostasis.

Authors:  Xinyu Zhou; Peihui Lin; Daiju Yamazaki; Ki Ho Park; Shinji Komazaki; S R Wayne Chen; Hiroshi Takeshima; Jianjie Ma
Journal:  Circ Res       Date:  2014-02-14       Impact factor: 17.367

9.  P2X4 receptors in activated C8-B4 cells of cerebellar microglial origin.

Authors:  Estelle Toulme; Angie Garcia; Damien Samways; Terrance M Egan; Monica J Carson; Baljit S Khakh
Journal:  J Gen Physiol       Date:  2010-03-15       Impact factor: 4.086

10.  Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptors.

Authors:  Gary Mo; Louis-Philippe Bernier; Qi Zhao; Anne-Julie Chabot-Doré; Ariel R Ase; Diomedes Logothetis; Chang-Qing Cao; Philippe Séguéla
Journal:  Mol Pain       Date:  2009-08-11       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.